Yahoo Web Search

Search results

1. Top Stories

   • 

     CNN.com

     FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN

     1 day ago

   • 

     Investor's Business Daily

     Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK

     1 day ago

   • 

     Investor's Business Daily

     Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?

     1 day ago

   View all

2. www.fda.gov › covid-19-vaccinesCOVID-19 Vaccines | FDA - U.S. Food and Drug Administration

   www.fda.gov › covid-19-vaccines

   • Cached

   The FDA amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age...

3. www.fda.gov › media › 144638Moderna COVID-19 Vaccine fact sheet for recipients and caregivers

   www.fda.gov › media › 144638

   The Moderna COVID-19 Vaccine has received EUA from FDA to provide: . • a two-dose primary series to individuals 18 years of age and older; . • a third primary series dose to...

4. www.fda.gov › news-events › press-announcementsCoronavirus (COVID-19) Update: FDA Takes Key Action by ...

   www.fda.gov › news-events › press-announcements

   • Cached

   Jan 31, 2022 · Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as...

5. news.modernatx.com › news › news-detailsModerna Announces FDA Authorization of Third Dose of COVID-19 ...

   news.modernatx.com › news › news-details

   • Cached

   Aug 13, 2021 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 13, 2021-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the emergency use authorization for the Moderna COVID-19 vaccine (mRNA-1273) to include a ...

6. news.modernatx.com › news › news-detailsModerna Receives U.S. FDA Approval for Updated COVID-19 Vaccine

   news.modernatx.com › news › news-details

   • Cached

   Sep 11, 2023 · CAMBRIDGE, MA / ACCESSWIRE / September 11, 2023 / Moderna, Inc. (NASDAQ:MRNA) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application(sBLA) for Spikevax® for ages 12 years and above. Emergency Use Authorization (EUA) for the Moderna COVID-19 Vaccine was also received for ...

7. www.npr.org › sections › health-shotsCDC Recommends 3rd Vaccine Dose For Immunocompromised People

   www.npr.org › sections › health-shots

   Aug 13, 2021 · The CDC is officially recommending a third dose of the Pfizer or Moderna vaccine for people with weakened immune systems. It follows the FDA authorization a day earlier.

8. People also ask

   Can you get a third dose of Moderna?

   • A: The FDA has only authorized third doses from the same manufacturer as the first two doses, such as three shots of Pfizer or three shots of Moderna. This is because studies on third doses from different manufacturers have not yet been conducted.

   The difference between COVID-19 ‘third doses’ and ...

   news.emory.edu/stories/2021/09/difference_between_covid19_third_doses_and_boosters/index.html

   See all results for this question

   When will Moderna be approved for a single booster dose?

   • On October 12, 2022, the FDA authorized the Moderna bivalent product (dark blue cap with gray border) and its administration for use as a single booster dose in individuals 12 - 17 years old in addition to the August 31, 2022, FDA authorization as a single booster dose in individuals 18 years and older.

   COVID-19 Vaccines and Monoclonal Antibodies | CMS

   www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/covid-19-vaccines-and-monoclonal-antibodies

   See all results for this question

   What is the dose for the Moderna 6 to 11 years dose?

   • •The Moderna 6 to 11 years doseis halfthe dose used for the primary course for people 12 years and older •The same as the booster dose (50μg per dose; 0.25mL) for people 12 years and older. Note: •At this stage, ATAGI does not recommend the use of mixed primary schedules in this age group

   MODERNA FOR CHILDREN AGED 6 to 11 YEARS OLD

   www.ppaonline.com.au/wp-content/uploads/2022/02/23-February-2022-Moderna-6-11yo-Update-Important-steps-for-Moderna-6-11yo-Vaccine-Clinic-Finder-Update.pdf

   See all results for this question

   How much does Moderna cost per dose?

   • The result is significantly dose dependent. They estimate the Moderna cost per dose (100 μg dose), at $2.85 and BioNTech cost per dose (30 μg dose) at $1.18. The author of the report asserts that the dominant cost is that of drug substance hence the cost differential between dose sizes.

   Novavax: Manufacturer, Commercialized COVID-Vaccine

   seekingalpha.com/article/4446352-novavax-manufacturer-and-commercialized-covid-vaccine-supplier-offers-deep-value

   See all results for this question

9. www.fdanews.com › articles › 203993-cdc-panelCDC Panel Supports Third Dose of Pfizer, Moderna ... - FDAnews

   www.fdanews.com › articles › 203993-cdc-panel

   • Cached

   Aug 16, 2021 · An advisory panel assembled by the Centers for Disease Control and Prevention (CDC) voted unanimously on Friday to endorse the FDA’s expanded Emergency Use Authorizations allowing a third dose of the Pfizer/BioNTech and Moderna COVID-19 vaccines for certain immunocompromised individuals.